Twist Bioscience Corp (TWST NASDAQ) stock market data APIs
$145.1357
-8.42(-5.8%)
as of October 15, 2026
Try our APIs with
free plan!
Twist Bioscience Corp Financial Data Overview
Price chart is built with
Anychart
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc and Lilly TuneLab. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Prev. Close
145.1357
Open
136.7109
High
148.2001
Low
129.9022
52 wk Range
23.3-219.71
Market Cap
9 580 M
Shares Outstanding
66 301 K
Revenue
432 M
EPS
-0.56
Beta
2.192
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Twist Bioscience Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Twist Bioscience Corp data using free add-ons & libraries
Get Twist Bioscience Corp Fundamental Data
Twist Bioscience Corp Fundamental data includes:
- Net Revenue: 432 M
- EBITDA: -115 282 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-03
- EPS/Forecast: -0.5
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Twist Bioscience Corp News
New
FTC seeks contempt finding against Martin Shkreli for alleged pharma ban violation
Investing.com -- The Federal Trade Commission and seven states are seeking to hold Martin Shkreli in contempt of court, alleging that the former pharmaceutical executive violated a lifetime ban on par...
Is Twist Bioscience (TWST) Quietly Becoming Core Infrastructure for AI-Driven Biofoundry Platforms?
Recent industry analysis identified Twist Bioscience as a key company in the expanding global biofoundry-as-a-service market, which is projected to reach about US$4.38 billion by 2030, reflecting grow...
Biofoundry-as-a-Service Global Market Report 2026 | Capitalize on 21.6% CAGR with GenScript, Ginkgo Bioworks, Twist Bioscience and Codexis Driving AI Automation
Company Logo Boost ROI with modular, automated biofoundries and AI/cloud-based DBTL workflows to cut manual work, speed development, improve reproducibility, and scale production. Dublin, Oct. 12, 2...
Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera
Company Logo Boost ROI with AI-led design, automated high-throughput screening, customizable libraries, local production and diversified sourcing to cut costs and speed development. Dublin, Oct. 12,...
Get Twist Bioscience Corp fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.